Amneal Pharmaceuticals, Inc. (AMRX): Price and Financial Metrics


Amneal Pharmaceuticals, Inc. (AMRX): $2.34

0.02 (+0.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AMRX POWR Grades

  • AMRX scores best on the Value dimension, with a Value rank ahead of 99.22% of US stocks.
  • AMRX's strongest trending metric is Growth; it's been moving up over the last 26 weeks.
  • AMRX ranks lowest in Momentum; there it ranks in the 10th percentile.

AMRX Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for AMRX is 7.19 -- better than 94.76% of US stocks.
  • With a price/sales ratio of 0.34, AMNEAL PHARMACEUTICALS INC has a higher such ratio than only 11.09% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 11.84 for AMNEAL PHARMACEUTICALS INC; that's greater than it is for 94.25% of US stocks.
  • If you're looking for stocks that are quantitatively similar to AMNEAL PHARMACEUTICALS INC, a group of peers worth examining would be ACIW, MSGM, SEAC, INPX, and CEMI.
  • Visit AMRX's SEC page to see the company's official filings. To visit the company's web site, go to www.amneal.com.

AMRX Valuation Summary

  • AMRX's price/earnings ratio is -5.4; this is 123.38% lower than that of the median Healthcare stock.
  • Over the past 57 months, AMRX's price/sales ratio has gone down 5.4.

Below are key valuation metrics over time for AMRX.

Stock Date P/S P/B P/E EV/EBIT
AMRX 2022-12-05 0.3 2.4 -5.4 134.5
AMRX 2022-12-02 0.3 2.5 -5.6 135.2
AMRX 2022-12-01 0.4 2.6 -5.9 136.9
AMRX 2022-11-30 0.4 2.6 -5.9 136.8
AMRX 2022-11-29 0.4 2.7 -6.0 137.3
AMRX 2022-11-28 0.3 2.5 -5.6 135.1

AMRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMRX has a Quality Grade of C, ranking ahead of 25.42% of graded US stocks.
  • AMRX's asset turnover comes in at 0.514 -- ranking 77th of 682 Pharmaceutical Products stocks.
  • 500 - Internal server error

The table below shows AMRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.514 0.343 0.037
2021-03-31 0.495 0.320 0.031
2020-12-31 0.483 0.315 0.032
2020-09-30 0.466 0.304 0.028
2020-06-30 0.440 0.283 0.063
2020-03-31 0.419 0.270 0.060

AMRX Stock Price Chart Interactive Chart >

Price chart for AMRX

AMRX Price/Volume Stats

Current price $2.34 52-week high $5.13
Prev. close $2.32 52-week low $1.95
Day low $2.25 Volume 2,539,000
Day high $2.36 Avg. volume 873,620
50-day MA $2.25 Dividend yield N/A
200-day MA $3.10 Market Cap 710.41M

Amneal Pharmaceuticals, Inc. (AMRX) Company Bio


Amneal Pharmaceuticals (formerly Impax Laboratories) develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. The company was founded in 1993 and is based in Hayward, California.


AMRX Latest News Stream


Event/Time News Detail
Loading, please wait...

AMRX Latest Social Stream


Loading social stream, please wait...

View Full AMRX Social Stream

Latest AMRX News From Around the Web

Below are the latest news stories about AMNEAL PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMRX as an investment opportunity.

Where Do Analysts Think The Amneal Pharmaceuticals Inc. (NYSE: AMRX) Is Going

Amneal Pharmaceuticals Inc. (NYSE:AMRX) price closed lower on Friday, November 25, dropping -1.24% below its previous close. A look at the daily price movement shows that the last close reads $2.42, with intraday deals fluctuated between $2.37 and $2.415. The company’s 5Y monthly beta was ticking 1.26. Taking into account the 52-week price action we … Where Do Analysts Think The Amneal Pharmaceuticals Inc. (NYSE: AMRX) Is Going Read More »

Stocks Register | November 28, 2022

Amneal Pharmaceuticals Inc. (AMRX) did well last session?

The share price of Amneal Pharmaceuticals Inc. (NYSE:AMRX) rose to $2.36 per share on Tuesday from $2.26. While Amneal Pharmaceuticals Inc. has overperformed by 4.42%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMRX fell by -47.90%, with highs and lows ranging from $5.13 to $1.95, […]

US Post News | November 23, 2022

Amneal to Participate at Upcoming Investor Conferences

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that the management team will attend the following investor conferences: Piper Sandler 34th Annual Healthcare Conference December 1, 2022 New York, New York 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 San Francisco, California Presentation – 2:15 PM Pacific Time A live webcast of the J.P. Morgan Healthcare conference presentation will be accessible through the Investo

Business Wire | November 23, 2022

Amneal Launches Second Biosimilar with RELEUKO® (filgrastim-ayow) in the United States

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the commercial launch of RELEUKO® (filgrastim-ayow), a biosimilar referencing Neupogen®. RELEUKO® is used to treat neutropenia which is commonly experienced by patients undergoing chemotherapy. This product was developed in collaboration with Kashiv Biosciences, LLC located in Chicago, Illinois. “RELEUKO is our second U.S. biosimilar launch and represents the next step in bu

Business Wire | November 22, 2022

Amneal Launches Second Biosimilar with RELEUKO (filgrastim-ayow) in the United States

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the commercial launch of RELEUKO (filgrastim-ayow), a biosimilar referencing Neupogen. RELEUKO is used to treat neutropenia which is commonly experienced by patients undergoing chemotherapy. This product was developed in collaboration with Kashiv Biosciences, LLC located in Chicago, Illinois. “RELEUKO

Wallstreet:Online | November 22, 2022

Read More 'AMRX' Stories Here

AMRX Price Returns

1-mo 4.00%
3-mo 1.30%
6-mo -26.42%
1-year -42.79%
3-year -33.14%
5-year -86.24%
YTD -51.15%
2021 4.81%
2020 -5.19%
2019 -64.38%
2018 -18.74%
2017 25.66%

Continue Researching AMRX

Here are a few links from around the web to help you further your research on Amneal Pharmaceuticals Inc's stock as an investment opportunity:

Amneal Pharmaceuticals Inc (AMRX) Stock Price | Nasdaq
Amneal Pharmaceuticals Inc (AMRX) Stock Quote, History and News - Yahoo Finance
Amneal Pharmaceuticals Inc (AMRX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8389 seconds.